183 related articles for article (PubMed ID: 36478294)
1. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma.
Hermans MM; Rietman AB; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; de Wildt SN; Breugem CC; de Graaf M; Raphael MF; Pasmans SGMA
Eur J Pediatr; 2023 Feb; 182(2):757-767. PubMed ID: 36478294
[TBL] [Abstract][Full Text] [Related]
2. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.
Hermans MM; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; Raphael MF; de Graaf M; Breugem CC; de Wildt SN; Okkerse JME; Pasmans SGMA; Rietman AB
Dermatology; 2024; 240(2):216-225. PubMed ID: 38228125
[TBL] [Abstract][Full Text] [Related]
3. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma.
Hermans MM; Breugem CC; Schappin R; Jonge Poerink E; Mendels EJ; Ragamin A; Breur JMPJ; Langeveld HR; Raphael MF; De Laat PCJ; De Wildt SN; Rietman AB; Pasmans SGMA; De Graaf M
Acta Derm Venereol; 2022 Oct; 102():adv00788. PubMed ID: 35506358
[TBL] [Abstract][Full Text] [Related]
4. Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma.
González-Llorente N; Del Olmo-Benito I; Muñoz-Ollero N; Descalzo MA; García-Doval I; Torrelo A
Pediatr Dermatol; 2017 Sep; 34(5):554-558. PubMed ID: 28804922
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
6. Oral atenolol compared to oral propranolol for infantile hemangioma.
Meza Viteri V; Aranibar L
Medwave; 2023 Dec; 23(11):e2753. PubMed ID: 38061014
[TBL] [Abstract][Full Text] [Related]
7. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
[TBL] [Abstract][Full Text] [Related]
8. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.
Wang Q; Xiang B; Chen S; Ji Y
Australas J Dermatol; 2019 Aug; 60(3):181-185. PubMed ID: 30515761
[TBL] [Abstract][Full Text] [Related]
10. Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.
Chen T; Gudipudi R; Nguyen SA; Carroll W; Clemmens C
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):332-340. PubMed ID: 35466712
[TBL] [Abstract][Full Text] [Related]
11. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
12. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age.
Moyakine AV; Spillekom-van Koulil S; van der Vleuten CJM
J Am Acad Dermatol; 2017 Jul; 77(1):105-108. PubMed ID: 28190620
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers.
Hermans MM; Pasmans SGMA; De Graaf M; Ragamin A; Mendels EJ; Breur JMPJ; Langeveld HR; Raphael MF; De Laat PCJ; De Wildt SN; Rietman AB; Breugem CC; Schappin R
Acta Derm Venereol; 2023 Aug; 103():adv5286. PubMed ID: 37649330
[TBL] [Abstract][Full Text] [Related]
14. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
[TBL] [Abstract][Full Text] [Related]
15. Oral Atenolol for Infantile Hemangioma: Case Series of 46 Infants.
Calderón-Castrat X; Velásquez F; Castro R; Ballona R
Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):59-62. PubMed ID: 31759456
[TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years.
Moyakine AV; Kerstjens JM; Spillekom-van Koulil S; van der Vleuten CJ
J Am Acad Dermatol; 2016 Jul; 75(1):59-63.e1. PubMed ID: 27021240
[TBL] [Abstract][Full Text] [Related]
17. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
18. No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age.
Li L; Wei L; Xu ZG; Ma L
Am J Clin Dermatol; 2019 Apr; 20(2):289-293. PubMed ID: 30618026
[TBL] [Abstract][Full Text] [Related]
19. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
Gumina ME; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
[TBL] [Abstract][Full Text] [Related]
20. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
